3 results
Approved WMOCompleted
To demonstrate superiority with regard to Progression Free Survival based on an Independent Review Committeeassessment of avelumab versus platinum-based doublet in NSCLC subjects with PD-L1+
Approved WMOCompleted
To obtain the safety and effectiveness data necessary to support a Premarket Approval (PMA) Application to the U.S. Food and Drug Administration (FDA)
Approved WMORecruiting
Our study at 'de Waag' (an outpatient forensic mental health institution) would provide a first impression of the added value of adding VR to the treatment of aggression regulation problems.Results from the study are also useful for…